Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001043044 | SCV001206755 | likely benign | Qualitative or quantitative defects of dysferlin | 2024-03-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002551526 | SCV003569868 | uncertain significance | Inborn genetic diseases | 2021-08-30 | criteria provided, single submitter | clinical testing | The c.4401C>G (p.I1467M) alteration is located in exon 40 (coding exon 40) of the DYSF gene. This alteration results from a C to G substitution at nucleotide position 4401, causing the isoleucine (I) at amino acid position 1467 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001277417 | SCV001464366 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-08-30 | no assertion criteria provided | clinical testing |